drug delivery

News

Roche preps filings for new Ocrevus injection

A subcutaneous (SC) injection version of Roche’s big-selling multiple sclerosis therapy Ocrevus has matched the current intravenous form in a clinical trial and, according

R&D

Partner Content

2nd Lipid Nanoparticle Development Europe Summit

Accurately Predict LNP-Payload's PKPD & Biodistribution for Safe, Targeted Delivery

News

Argenx gets FDA nod for first subcutaneous gMG therapy

The market for drugs to treat the muscle-wasting disease generalised myasthenia gravis (gMG) is getting more crowded, and Argenx has just claimed an FDA approval that coul

News

Rani’s ‘robotic’ pill delivers injectable osteoporosis drug

US biotech Rani Therapeutics has shown that its oral formulation of a drug for osteoporosis that currently has to be delivered by injection worked as hoped in a first-in-h

News

Takeda tries again with subcutaneous Entyvio

More than three years after it was first rejected by the FDA, Takeda's subcutaneous (SC) formulation of Entyvio has been resubmitted as a maintenance therapy for ulcerativ

R&D